NeoPhore is creating novel small molecule immuno-oncology therapeutics. NeoPhore's drugs target genetic mechanisms that both clinical and lab validation studies suggest will promote neoantigen creation and diversity across numerous cancers. Alone or in combination with other cancer immunotherapies, drugs that spark cancer neoantigen creation are designed to stimulate the immune system and improve outcomes for patients who fail to benefit from the current generation of cancer immunity therapeutics.
View Top Employees from NeoPhore Ltd| Website | http://www.neophore.com |
| Revenue | $5 million |
| Funding | $8.1 million |
| Employees | 16 (9 on RocketReach) |
| Founded | 2017 |
| Phone | +44 330 128 9990 |
| Technologies |
JavaScript,
HTML,
Twitter
+15 more
(view full list)
|
| Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Biotechnology, Healthcare, Science and Engineering, Simulation, Software, Therapeutics, Health Care, Translation Service, Professional Services |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54138 Companies, NAICS Code 54 Companies, NAICS Code 5413 Companies, NAICS Code 541 Companies |
Looking for a particular NeoPhore Ltd employee's phone or email?
NeoPhore Ltd Questions
The NeoPhore Ltd annual revenue was $5 million in 2024.
Stephen Over is the CFO of NeoPhore Ltd.
9 people are employed at NeoPhore Ltd.
The NAICS codes for NeoPhore Ltd are [54138, 54, 5413, 541].
The SIC codes for NeoPhore Ltd are [87, 873].
Top NeoPhore Ltd Employees
-
2
-
4
-
31
-
1
-
11
Related Companies
